1348 related articles for article (PubMed ID: 26573228)
1. LPS-induced TNF-α factor mediates pro-inflammatory and pro-fibrogenic pattern in non-alcoholic fatty liver disease.
Ceccarelli S; Panera N; Mina M; Gnani D; De Stefanis C; Crudele A; Rychlicki C; Petrini S; Bruscalupi G; Agostinelli L; Stronati L; Cucchiara S; Musso G; Furlanello C; Svegliati-Baroni G; Nobili V; Alisi A
Oncotarget; 2015 Dec; 6(39):41434-52. PubMed ID: 26573228
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-22 ameliorates liver fibrogenesis by attenuating hepatic stellate cell activation and downregulating the levels of inflammatory cytokines.
Lu DH; Guo XY; Qin SY; Luo W; Huang XL; Chen M; Wang JX; Ma SJ; Yang XW; Jiang HX
World J Gastroenterol; 2015 Feb; 21(5):1531-45. PubMed ID: 25663772
[TBL] [Abstract][Full Text] [Related]
3. Caffeic acid phenethyl ester attenuates pro-inflammatory and fibrogenic phenotypes of LPS-stimulated hepatic stellate cells through the inhibition of NF-κB signaling.
Zhao WX; Wang L; Yang JL; Li LZ; Xu WM; Li T
Int J Mol Med; 2014 Mar; 33(3):687-94. PubMed ID: 24378685
[TBL] [Abstract][Full Text] [Related]
4. Adipose tissue-derived stem cells prevent fibrosis in murine steatohepatitis by suppressing IL-17-mediated inflammation.
Yamato M; Sakai Y; Mochida H; Kawaguchi K; Takamura M; Usui S; Seki A; Mizukoshi E; Yamashita T; Yamashita T; Ishida K; Nasti A; Tuyen HTB; Komura T; Yoshida K; Wada T; Honda M; Kaneko S
J Gastroenterol Hepatol; 2019 Aug; 34(8):1432-1440. PubMed ID: 30828861
[TBL] [Abstract][Full Text] [Related]
5. Insulin resistance promotes Lysyl Oxidase Like 2 induction and fibrosis accumulation in non-alcoholic fatty liver disease.
Dongiovanni P; Meroni M; Baselli GA; Bassani GA; Rametta R; Pietrelli A; Maggioni M; Facciotti F; Trunzo V; Badiali S; Fargion S; Gatti S; Valenti L
Clin Sci (Lond); 2017 Jun; 131(12):1301-1315. PubMed ID: 28468951
[TBL] [Abstract][Full Text] [Related]
6. Fluvastatin attenuates hepatic steatosis-induced fibrogenesis in rats through inhibiting paracrine effect of hepatocyte on hepatic stellate cells.
Chong LW; Hsu YC; Lee TF; Lin Y; Chiu YT; Yang KC; Wu JC; Huang YT
BMC Gastroenterol; 2015 Feb; 15():22. PubMed ID: 25886887
[TBL] [Abstract][Full Text] [Related]
7. Activin-A causes Hepatic stellate cell activation via the induction of TNFα and TGFβ in Kupffer cells.
Kiagiadaki F; Kampa M; Voumvouraki A; Castanas E; Kouroumalis E; Notas G
Biochim Biophys Acta Mol Basis Dis; 2018 Mar; 1864(3):891-899. PubMed ID: 29287776
[TBL] [Abstract][Full Text] [Related]
8. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.
Ganz M; Bukong TN; Csak T; Saha B; Park JK; Ambade A; Kodys K; Szabo G
J Transl Med; 2015 Jun; 13():193. PubMed ID: 26077675
[TBL] [Abstract][Full Text] [Related]
9. Silymarin suppresses hepatic stellate cell activation in a dietary rat model of non-alcoholic steatohepatitis: analysis of isolated hepatic stellate cells.
Kim M; Yang SG; Kim JM; Lee JW; Kim YS; Lee JI
Int J Mol Med; 2012 Sep; 30(3):473-9. PubMed ID: 22710359
[TBL] [Abstract][Full Text] [Related]
10. Cell-specific PPARγ deficiency establishes anti-inflammatory and anti-fibrogenic properties for this nuclear receptor in non-parenchymal liver cells.
Morán-Salvador E; Titos E; Rius B; González-Périz A; García-Alonso V; López-Vicario C; Miquel R; Barak Y; Arroyo V; Clària J
J Hepatol; 2013 Nov; 59(5):1045-53. PubMed ID: 23831119
[TBL] [Abstract][Full Text] [Related]
11. Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation.
Bates J; Vijayakumar A; Ghoshal S; Marchand B; Yi S; Kornyeyev D; Zagorska A; Hollenback D; Walker K; Liu K; Pendem S; Newstrom D; Brockett R; Mikaelian I; Kusam S; Ramirez R; Lopez D; Li L; Fuchs BC; Breckenridge DG
J Hepatol; 2020 Oct; 73(4):896-905. PubMed ID: 32376414
[TBL] [Abstract][Full Text] [Related]
12. A retinoic acid receptor β2 agonist reduces hepatic stellate cell activation in nonalcoholic fatty liver disease.
Trasino SE; Tang XH; Jessurun J; Gudas LJ
J Mol Med (Berl); 2016 Oct; 94(10):1143-1151. PubMed ID: 27271256
[TBL] [Abstract][Full Text] [Related]
13. Assessing the combined impact of fatty liver-induced TGF-β1 and LPS-activated macrophages in fibrosis through a novel 3D serial section methodology.
Ishiyama S; Hayatsu M; Toriumi T; Tsuda H; Watanabe K; Kasai H; Kishigami S; Mochizuki K; Mikami Y
Sci Rep; 2024 May; 14(1):11404. PubMed ID: 38762616
[TBL] [Abstract][Full Text] [Related]
14. GDF11 induces mild hepatic fibrosis independent of metabolic health.
Frohlich J; Kovacovicova K; Mazza T; Emma MR; Cabibi D; Foti M; Sobolewski C; Oben JA; Peyrou M; Villarroya F; Soresi M; Rezzani R; Cervello M; Bonomini F; Alisi A; Vinciguerra M
Aging (Albany NY); 2020 Oct; 12(20):20024-20046. PubMed ID: 33126224
[TBL] [Abstract][Full Text] [Related]
15. TMEM100 mediates inflammatory cytokines secretion in hepatic stellate cells and its mechanism research.
Pan LX; Li LY; Zhou H; Cheng SQ; Liu YM; Lian PP; Li L; Wang LL; Rong SJ; Shen CP; Li J; Xu T
Toxicol Lett; 2019 Dec; 317():82-91. PubMed ID: 30639579
[TBL] [Abstract][Full Text] [Related]
16. A20 Attenuates Liver Fibrosis in NAFLD and Inhibits Inflammation Responses.
Wang X; Ai L; Xu Q; Wu C; Chen Z; Su D; Jiang X; Fan Z
Inflammation; 2017 Jun; 40(3):840-848. PubMed ID: 28251449
[TBL] [Abstract][Full Text] [Related]
17. Sorafenib reduces steatosis-induced fibrogenesis in a human 3D co-culture model of non-alcoholic fatty liver disease.
Romualdo GR; Da Silva TC; de Albuquerque Landi MF; Morais JÁ; Barbisan LF; Vinken M; Oliveira CP; Cogliati B
Environ Toxicol; 2021 Feb; 36(2):168-176. PubMed ID: 32918399
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional repression of SIRT1 by protein inhibitor of activated STAT 4 (PIAS4) in hepatic stellate cells contributes to liver fibrosis.
Sun L; Fan Z; Chen J; Tian W; Li M; Xu H; Wu X; Shao J; Bian Y; Fang M; Xu Y
Sci Rep; 2016 Jun; 6():28432. PubMed ID: 27323886
[TBL] [Abstract][Full Text] [Related]
19. FXR agonist GW4064 alleviates endotoxin-induced hepatic inflammation by repressing macrophage activation.
Yao J; Zhou CS; Ma X; Fu BQ; Tao LS; Chen M; Xu YP
World J Gastroenterol; 2014 Oct; 20(39):14430-41. PubMed ID: 25339829
[TBL] [Abstract][Full Text] [Related]
20. Astaxanthin prevents TGFβ1-induced pro-fibrogenic gene expression by inhibiting Smad3 activation in hepatic stellate cells.
Yang Y; Kim B; Park YK; Koo SI; Lee JY
Biochim Biophys Acta; 2015 Jan; 1850(1):178-85. PubMed ID: 25450180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
